Upgrade to Chrome Upgrade to Firefox Upgrade to Microsoft Edge Upgrade to Safari
Skip to content
  • Services
    • Overview
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
    • Overview
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
  • About
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
  • Insights
    • Industry Insights
    • News
    • Publications
    • Industry Insights
    • News
    • Publications
    • Insights
    • News
    • Publications
  • Join us
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
  • Contact

NHS 10 year plan: Can using AI offer a solution to the NHS’ problems?

European expert consensus recommendations on the primary care use of direct oral anticoagulants in patients with venous thromboembolism

Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers

An update on anti-thrombotic therapy following transcatheter aortic valve implantation: expert cardiologist opinion from a UK and Ireland Delphi group

A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK

Clinical trial considerations in developing treatments for early stages of common, chronic kidney diseases: a scientific workshop cosponsored by the National Kidney Foundation and the US Food and Drug Administration

The role of sodium-glucose co-transporter-2 inhibitors in frail older adults with or without type 2 diabetes mellitus

Defining the role of SGLT2 inhibitors in primary care: time to think differently

Meeting the challenge of virtual diabetes care: a consensus viewpoint on the positioning and value of oral semaglutide in routine clinical practice

New therapeutic horizons in chronic kidney disease: the role of SGLT2 inhibitors in clinical practice

Next →
  • Services
  • Insights
  • Case studies
  • Services
  • Insights
  • Case studies
  • About us
  • Contact us
  • About us
  • Contact us
  • Privacy policy
  • Environmental policy
  • Privacy policy
  • Environmental policy
© 2026 Health Economics and Outcomes Research LTD, All Rights Reserved
GDPR verified badge
EcoVadis Committed badge for ESG performance
Carbon disclosure toolkit badge
Science Based Targets initiative (SBTi) validation logo

WE ARE COMMITTED TO SCIENCE-BASED CLIMATE TARGETS VALIDATED BY THE SBTI

  • Services
    • Global Market Access
    • Evidence Review & Synthesis
    • Health Economic Modelling
    • Health Technology Assessment
    • Data Science & Analytics
    • Value Communication
  • About
    • About HEOR
    • Our Ethos
    • Team
    • Case Studies
  • Insights
    • Insights
    • News
    • Publications
  • Join us
    • Our people
    • Learn & develop
    • Candidate journey
    • Latest vacancies
  • Contact